(Q73881573)
Statements
Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European Organization for Research and Treatment of Cancer Protocol no. 30924 (English)
S D Fossa
C N Sternberg
P H de Mulder
J H Schornagel
C Théodore
A T van Oosterom
F Witjes
M Spina
C J van Groeningen
C de Balincourt
L Collette
European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group